Imunon Inc (IMNN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.08M
Last updated: Nov 17, 2026 at 11:04 AM ET
Imunon Inc (IMNN) Competitors
The companies most similar to Imunon are Ernexa Therapeutics (ERNA), Liminatus Pharma, Inc. Class A Common Stock (LIMN) and Immuron Ltd ADR (IMRN). By market cap, Imunon ranks 6th of the 13 companies on this page; Exicure (XCUR) is the largest at $7.07M.
Peer Comparison
IMNN's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Imunon (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Immuron Ltd ADR (IMRN) | $7.06M | N/A | 0.9x | -47.7% | N/A | 7.2% | 0.00% |
| Onconetix Inc (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Can Fite Biopharma Ltd ADR (CANF) | $4.30M | N/A | 14.3x | 0.0% | -156.8% | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Alaunos Therapeutics Inc (TCRT) | $6.86M | N/A | N/A | 0.0% | N/A | -25.0% | 0.00% |
| NuCana PLC (NCNA) | $3.88M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Kiora Pharmaceuticals Inc (KPRX) | $5.44M | N/A | 6.2x | 0.0% | N/A | 0.0% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| Peer median | $3.95M | N/A | 3.6x | 0.0% | -202.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Imunon, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Immuron Ltd ADR (IMRN) | Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious... | |
| Onconetix Inc (ONCO) | Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. | ONCO competitors |
| Can Fite Biopharma Ltd ADR (CANF) | Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer... | |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Alaunos Therapeutics Inc (TCRT) | Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring... | TCRT competitors |
| NuCana PLC (NCNA) | NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. | NCNA competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Kiora Pharmaceuticals Inc (KPRX) | Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative... | KPRX competitors |
| Exicure Inc (XCUR) | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
Frequently Asked Questions About IMNN
Who are Imunon's main competitors?
The companies most similar to Imunon include Ernexa Therapeutics (ERNA), Liminatus Pharma, Inc. Class A Common Stock (LIMN), Immuron Ltd ADR (IMRN), Onconetix (ONCO) and Can Fite Biopharma Ltd ADR (CANF), listed from the closest match.
Who is Imunon's biggest competitor?
Exicure (XCUR) is the largest of the similar companies at $7.07M; Ernexa Therapeutics (ERNA) is the closest match by business profile, size, sector and industry.
How does IMNN stock compare with its competitors?
IMNN's net margin is 0.0% against a peer median of 0.0%.
Which of Imunon's competitors pays a higher dividend?
Imunon pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Imunon bigger than its competitors?
No. Imunon is 6th by market cap among the 13 companies on this page; the largest is Exicure (XCUR) at $7.07M.
IMNN pages: Overview, Earnings, Forecast, Financials, Competitors